{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-010674","form_type":"8-K","ticker":"NXPL","cik":"0001058307","company_name":"NextPlat Corp","filed_at":"2026-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.480469+00:00","generated_at":"2026-05-15T08:05:28.479523+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"NextPlat reports FY2025 revenue $54.3M, net loss $0.44/share; cost cuts of $2M+","bullets":["Revenue $54.3M, down 18% YoY; healthcare revenue fell to $39.7M, e-commerce rose to $14.6M.","Net loss attributable to common stockholders $11.7M ($0.44 per diluted share) vs $13.4M ($0.65) prior year.","Operating expenses cut 50% to $19.9M; headcount reduced >25%, $2M+ annualized cost savings.","Cash $13.7M, no meaningful debt, working capital $15M; gross margin fell to 20% from 26%.","New leadership: Rodney Barreto Chairman, David Phipps CEO, Amanda Ferrio CFO, Birute Norkute VP Healthcare."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-010674","json":"https://secwatch.observer/filing/0001437749-26-010674.json","markdown":"https://secwatch.observer/filing/0001437749-26-010674.md","text":"https://secwatch.observer/filing/0001437749-26-010674.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1058307/000143774926010674/0001437749-26-010674-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1058307/000143774926010674/nxpl20251122_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:05:28.479523+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6a5bfffc3f60f56acec9f3ce4f7e79774924e0f8","claim":"NextPlat Corp reported year ended December 31, 2025 results: revenue approximately $54.3 million, net income Net loss attributable to common stockholders for the year ended December 31, 2025, was approximately $11.7 million, or (, EPS ($0.44) per diluted share.","evidence_excerpt":"our shareholders for quite some time.” Fourth Quarter and Full Year 2025 Financial Highlights ● Consolidated revenue for the full year ended December 31, 2025, was approximately $54.3 million, compared to approximately $66.1 million for the prior year, an overall decrease of 18%. ○ Full year 2025 Healthcare Operations revenue decreased approximately $12.6 million to","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1058307/000143774926010674/0001437749-26-010674-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"year ended December 31, 2025"},{"label":"Revenue","value":"approximately $54.3 million"},{"label":"Net income","value":"Net loss attributable to common stockholders for the year ended December 31, 2025, was approximately $11.7 million, or ("},{"label":"EPS","value":"($0.44) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}